PHI circulars

The billing code format has been finalised and is commencing on 1 March 2025.

Update to the Terms of Reference and timeframes.

Requirement for insurers to keep information for the purposes of calculating the LHC loading throughout the lifetime of a person.

Clarification of the date when benefit amounts in the Prescribed List commence

Release of the Prescribed List post-listing review framework.

Hospital and second-tier updates.

We have released the first interim report for evaluation of the Prescribed List reforms

Second-tier updates.

Notice of new private hospital declaration.

We have released the analysis of stakeholder feedback in relation to PricewaterhouseCoopers’ report and recommendations on reforms to Part B

Notification about the 2024-25 Cost Recovery Implementation Statement (CRIS) and the annual NJRR levy
This circular is to advise stakeholders of two matters related to the National Joint Replacement Registry (NJRR).

Notice of new or amended hospital declaration status and/or second-tier default benefit eligibility

Notice of new private hospital declaration.

Hospital and second-tier updates.

Update on the post-listing review of surgical guides and biomodels.

The billing code format for parts A, C and D of the Prescribed List has been finalised and will be effective from 1 March 2025

Notice of new or amended hospital declaration status and/or second-tier default benefit eligibility.

Hospital and Second-tier Updates.

Notice of private hospital revocation and Hospital Provider Number transfer with new private hospital declaration.

Notice of new private hospital declaration.

Notice of Private Hospital Revocation.

Update to Prescribed List of Medical Devices and Human Tissue Products, effective 1 November 2024.

The Prescribed List of Medical Devices and Human Tissue Products (PL) will be updated on 1 November 2024

This statement describes how we recover the costs of administering the National Joint Replacement Registry.

Hospital and second-tier updates.